Pharmaceutical Clinical Trials
Full-service CRO support for Phase I-IV pharma trials in Georgia, Armenia, Israel and Uzbekistan
Pharma Trial Expertise
Pharmaceutical clinical trials demand rigorous protocol adherence, strong patient recruitment and clean, audit-ready data. aCROss Medical manages pharma studies across all phases - from first-in-human Phase I trials through large Phase III/IV outcome and post-marketing studies.
Our investigative site network spans leading hospitals and research centres across Georgia, Armenia, Israel and Uzbekistan, giving sponsors access to treatment-naive patient populations, experienced investigators and fast, predictable regulatory timelines.
Pharma Trial Services
- Regulatory strategy and submission for pharma studies (EMA, FDA IND, local MoH)
- Site feasibility and selection across our network of GCP-compliant investigator sites
- Patient recruitment and retention strategies for treatment-naive and rare disease populations
- Clinical monitoring - on-site and remote
- Investigational product (IP) management, storage and accountability
- Pharmacovigilance and SUSAR/SAE reporting per ICH E2A/E2B
- Data management and biostatistics from database build through lock
- Medical writing and regulatory submission support
Therapeutic Areas for Pharma Trials
aCROss Medical supports pharmaceutical trials across a broad range of specialties, with particular strength in:
- Cardiology - lipid-lowering agents, anticoagulants, heart failure therapies
- Neurology - neurodegenerative disease, epilepsy, migraine therapies
- Oncology - solid tumours, haematologic malignancies, immunotherapy
- Infectious Disease - antivirals, antibiotics, vaccine studies
- Respiratory - asthma, COPD, pulmonary fibrosis therapies
- Urology - BPH, overactive bladder, urologic oncology
- OBGYN - women's health and reproductive endocrinology
- ICU - critical care and sepsis therapeutics
Why Choose Our Countries for Pharma Trials
Georgia, Armenia, Israel and Uzbekistan each offer distinct advantages for pharmaceutical studies. Israel combines world-class academic medical centres with a thriving pharma R&D ecosystem. Georgia and Armenia offer fast regulatory and ethics committee timelines alongside competitive operational costs. Uzbekistan provides access to a large, treatment-naive patient pool ideal for studies with strict enrolment criteria.
Regulatory Compliance
All pharmaceutical trials conducted through aCROss Medical adhere to ICH E6(R2) Good Clinical Practice, applicable national regulatory and ethics committee requirements, and ICH safety reporting standards. Our regulatory team works closely with sponsors to ensure that submissions are complete, timelines are accurate and approvals are obtained efficiently.